InvestorsHub Logo

dcspka

04/20/14 1:19 AM

#20942 RE: guardiangel #20941

Since Provista IS once again including Lung Cancer Testing in their arsenal of products, it can only mean one thing- William Gartner is clearly part of their organization (he never left, just as you said). Excellent.

Gold Seeker

04/20/14 3:59 AM

#20945 RE: guardiangel #20941

Wolfie states that Provista is still developing the lung cancer test from Radient.

What source would an astute investor use? An old press release or the current website from Provistadx?

Obviously, Wolfie is using the old press release.

lakeshore555

04/20/14 9:32 AM

#20947 RE: guardiangel #20941

Let's look at Radient Pharmaceuticals on your "DD source."

www.bioportfolio.com/corporate/company/12463/Radient-Pharmaceuticals-Corporation.html

"Headquartered in Tustin, California, Radient Pharmaceuticals Corporation is an integrated pharmaceutical company devoted to the research, development, manufacturing, and marketing of diagnostic and premium skin care products. "

First of all, they are not headquartered anywhere -- there is no physical office. If anything, they are headquartered wherever MacLellan is at the moment. Second, they haven't done anything with "skin care products" since they lost Jade in 2009. Finally, no mention of cancer? According to YOUR DD source, Radient no longer has a cancer test.

Conclusion: just because Bioportfolio.com has the word "lung cancer test" in their description of a company does NOT mean that company is working on a lung cancer test today. But, by all means, anyone who wants the final answer on this question should contact Provista and ask. They answer emails, they answer their phone, they have a physical location, THEY OPERATE.

Now, please look at section 10 of the filings in your link: "NO" is checked on all of them.

"10. Business Combination Transaction
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? Answer: NO

They cannot lie on this filing. That money cannot be used for a merger or takeover.